Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
1486 Preliminary results from LuCa-MERIT-1, a phase I tri... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
1486 Preliminary results from LuCa-MERIT-1, a phase I trial evaluating BNT116, a fixed antigen mRNA vaccine, plus cemiplimab in advanced non-small cell lung cancer after progression on PD-1 inhibition
0
Authors
Akin Atmaca
•
Jürgen Alt
18 more
•
Uğur Şahin
Published
November 1, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Loading PDF viewer…
Supporters
Support the authors with ResearchCoin
Tip RSC
Topics
Cancer Oncology
Immunology
Medicine
Cancer Oncology
Immunology
Molecular Biology
Virology
Show all topics
DOI
10.1136/jitc-2024-sitc2024.1486
License
CC-BY-NC
Other Formats
PDF
